Register
Login
Browse by Topics
Adverse Effects and Comorbidities
Antiretroviral Management
Epidemiology and Natural History
Opportunistic Diseases and Coinfection
Pharmacology
Resistance
Special Populations
OR
Conference Coverage
Retroviruses 2008
Chicago 2007
Madrid 2007
Sydney 2007
Pharmacology 2007
Resistance 2007
More...
Conference Calendar
Journal Options
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Q2 2006
More...
Management Series
Integrase Inhibitors
Psychiatric Disorders
When to Start
Cardiovascular Risk 2006
NNRTI Update
Initial PI
Resistance
Fine Tuning
NeuroAIDS
Insulin Resistance
Fixed-Dose NRTIs
Multiclass Resistance
NNRTI Strategies
Pharmacokinetics
NRTI Backbone
Double-Boosted PIs
Cardiovascular Risk
More...
Treatment Updates
Stay Tuned
FAQ on Cardiovascular Risk
Optimal Timing
Rethinking NNRTIs
Simple
Managing CV Risk
Tropism
Right From the Start
New Classes
Next Generation
Metabolic Complications
Grand Rounds
More...
Annual Updates
2007 Annual Update
2006 Annual Update
2005 Annual Update
2004 Annual Update
2003 Annual Update
2002 Annual Update
More...
Interactive Cases
Treatment-Experienced Patients
Use of Resistance Testing
Cardiovascular Vignettes
Resistance Vignettes
More...
Resources
Live Events
Expert Viewpoints
Bookstore
Animation Downloads
Slideset Downloads
Interactive Tools
Webcasts
CME Options
Portuguese
Guidelines
More...
CCO
>
HIV
>
Resources
>
Webcasts
Saturday, May 17, 2008
Webcasts
Novel Classes of Antiretrovirals: Update on CCR5 Antagonists and Integrase Inhibitors
Novel Classes of Antiretrovirals: Update on CCR5 Antagonists and Integrase Inhibitors
New Strategies for Regaining Control of HIV Replication in Treatment-Experienced Patients
Webcast: New Strategies for Regaining Control of HIV Replication in Treatment-Experienced Patients
CCO
>
HIV
>
Resources
>
Webcasts